Ross Muken
Stock Analyst at Evercore ISI Group
(2.16)
# 2,687
Out of 4,748 analysts
44
Total ratings
57.14%
Success rate
3.48%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Ross Muken
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRL Charles River Laboratories International | Maintains: In-Line | $190 → $225 | $165.57 | +35.89% | 6 | Nov 7, 2024 | |
| PDCO Patterson Companies | Maintains: In-Line | $23 → $22 | $30.99 | -29.01% | 4 | Oct 8, 2024 | |
| ICLR ICON Public Limited Company | Maintains: Outperform | $360 → $350 | $201.72 | +73.51% | 7 | Oct 8, 2024 | |
| HSIC Henry Schein | Maintains: In-Line | $70 → $74 | $80.03 | -7.53% | 8 | Oct 8, 2024 | |
| A Agilent Technologies | Maintains: In-Line | $126 → $130 | $151.38 | -14.12% | 11 | Jul 2, 2024 | |
| QGEN Qiagen | Downgrades: In-Line | n/a | $44.51 | - | 2 | Jul 16, 2019 | |
| CAH Cardinal Health | Initiates: In-Line | $67 | $128.26 | -47.76% | 2 | Jan 5, 2018 | |
| ILMN Illumina | Initiates: Outperform | $250 | $133.01 | +87.96% | 2 | Jan 4, 2018 | |
| TMO Thermo Fisher | Initiates: Outperform | $220 | $606.74 | -63.74% | 1 | Jan 4, 2018 | |
| MBLY Mobileye | Downgrades: In-Line | n/a | $16.31 | - | 1 | Mar 13, 2017 |
Charles River Laboratories International
Nov 7, 2024
Maintains: In-Line
Price Target: $190 → $225
Current: $165.57
Upside: +35.89%
Patterson Companies
Oct 8, 2024
Maintains: In-Line
Price Target: $23 → $22
Current: $30.99
Upside: -29.01%
ICON Public Limited Company
Oct 8, 2024
Maintains: Outperform
Price Target: $360 → $350
Current: $201.72
Upside: +73.51%
Henry Schein
Oct 8, 2024
Maintains: In-Line
Price Target: $70 → $74
Current: $80.03
Upside: -7.53%
Agilent Technologies
Jul 2, 2024
Maintains: In-Line
Price Target: $126 → $130
Current: $151.38
Upside: -14.12%
Qiagen
Jul 16, 2019
Downgrades: In-Line
Price Target: n/a
Current: $44.51
Upside: -
Cardinal Health
Jan 5, 2018
Initiates: In-Line
Price Target: $67
Current: $128.26
Upside: -47.76%
Illumina
Jan 4, 2018
Initiates: Outperform
Price Target: $250
Current: $133.01
Upside: +87.96%
Thermo Fisher
Jan 4, 2018
Initiates: Outperform
Price Target: $220
Current: $606.74
Upside: -63.74%
Mobileye
Mar 13, 2017
Downgrades: In-Line
Price Target: n/a
Current: $16.31
Upside: -